/Report: 1st coronavirus vaccine can protect against disease, but not infection

Report: 1st coronavirus vaccine can protect against disease, but not infection

NEW YORK – A recent article suggests that struggling under the weight of COVID-19 could lead to a weakened vaccine to frustrate the development of the economy.

According to Bloomberg, Robin Schattak, a leading professor of experimental shots at Imperial College London, said that although the “knock-out” vaccine would be ideal, early vaccines could carry limitations.

“Is this protection against infection?” Shotk told the news agency. “Is it protection against illness? Is it protection against serious diseases? It is a very effective vaccine that protects against deadly diseases. “

A vaccine showed an effect on the disease but not an infection, the outlet wrote

“Vaccines need to be protected from disease, not contagious,” said Dennis Burton, an immunologist and vaccine researcher at Scripps Research in La Jolla, California.

This type of vaccine can lead to complacency in areas tired of the lockdown, a drug development expert warned.

“My guess is that someday after the vaccination, they’ll think, ‘I can get back to normal. Everything will be fine, ”said Michael Kinch, associate vice-chancellor of Washington University in St. Louis. “They’re not necessarily going to realize that they can still be infected.”

The outlet noted that a few, if any, vaccines are 100 percent effective in all recipients. The World Health Organization (WHO) listed 13 vaccine candidates in June, of which 10 were classified under clinical evaluation.

According to Food and Drug Administration spokesman Michael Felbaum, the data supports the benefits of the vaccine if the agency would consider an indication of serious disease prevention. For the license, a vaccine will not be needed to protect against infection, he said.

For example, Moderna, Inc. In its June 11 update, the company said the primary end of its final phase of testing was the notable COVID-19 disease prevention; Key secondary endpoints include infection prevention and severe COVID-19 disease.

According to Kinch, “a truly perfect vaccine will never be found” but follow-up on incomplete yet practical vaccines is a possibility.

Click here to read more stories from Fox News

.